The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Wilkinson, C. P., Ferris, F. L., Klein, R. E., Lee, P. P., Agardh, C. D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R., & Verdaguer, J. T. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,743
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691
Elman, M. J., Aiello, L. P., Beck, R. W., Bressler, N. M., Bressler, S. B., Edwards, A. R., Ferris, F. L., Friedman, S. M., Glassman, A. R., Miller, K. M., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.031 · Cited by 1,428
Mitchell, P., Bandello, F., Schmidt-Erfurth, U., Lang, G. E., Massin, P., Schlingemann, R. O., Sutter, F., Simader, C., Burian, G., Gerstner, O., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.031 · Cited by 1,326
Self-citationThe Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1987) · Ophthalmology · doi:10.1016/s0161-6420(87)33525-0 · Cited by 1,249
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34102-1 · Cited by 981
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)
Massin, P., Bandello, F., Garweg, J. G., Hansen, L. L., Harding, S. P., Larsen, M., Mitchell, P., Sharp, D., Wolf-Schnurrbusch, U. E. K., Gekkieva, M., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0493 · Cited by 720
Treatment Techniques and Clinical Guidelines for Photocoagulation of Diabetic Macular Edema
(1987) · Ophthalmology · doi:10.1016/s0161-6420(87)33527-4 · Cited by 544
Gardner, T. W., Antonetti, D. A., Barber, A. J., LaNoue, K. F., & Levison, S. W. (2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00387-9 · Cited by 535
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Nguyen, Q. D., Shah, S. M., Khwaja, A. A., Channa, R., Hatef, E., Do, D. V., Boyer, D., Heier, J. S., Abraham, P., Thach, A. B., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.08.016 · Cited by 532
Self-citationMortality Trends in Men and Women with Diabetes, 1971 to 2000
Gregg, E. W., Gu, Q., Cheng, Y. J., Venkat Narayan, K. M., & Cowie, C. C. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-3-200708070-00167 · Cited by 463
A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema
(2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.05.062 · Cited by 451
Bresnick, G. H. (1986) · Ophthalmology · doi:10.1016/s0161-6420(86)33650-9 · Cited by 410
Predicted biological activity of intravitreal VEGF Trap
Stewart, M. W., & Rosenfeld, P. J. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.134874 · Cited by 375
Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema
Nguyen, Q. D., Tatlipinar, S., Shah, S. M., Haller, J. A., Quinlan, E., Sung, J., Zimmer-Galler, I., Do, D. V., & Campochiaro, P. A. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.06.068 · Cited by 351
Self-citationRakic, J.-M., Lambert, V., Devy, L., Luttun, A., Carmeliet, P., Claes, C., Nguyen, L., Foidart, J.-M., Noe¨l, A., & Munaut, C. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1092 · Cited by 321
Chun, D. W., Heier, J. S., Topping, T. M., Duker, J. S., & Bankert, J. M. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.04.033 · Cited by 295
Self-citation(2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.4.469 · Cited by 274
The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with Diabetic Macular Edema
Do, D. V., Schmidt-Erfurth, U., Gonzalez, V. H., Gordon, C. M., Tolentino, M., Berliner, A. J., Vitti, R., Rückert, R., Sandbrink, R., Stein, D., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.018 · Cited by 253
Self-citationDvorak, H. F., Orenstein, N. S., Carvalho, A. C., Churchill, W. H., Dvorak, A. M., Galli, S. J., Feder, J., Bitzer, A. M., Rypysc, J., & Giovinco, P. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.122.1.166 · Cited by 230
Supplemental Oxygen Improves Diabetic Macular Edema: A Pilot Study
Nguyen, Q. D., Shah, S. M., Van Anden, E., Sung, J. U., Vitale, S., & Campochiaro, P. A. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0557 · Cited by 178
Self-citationThe role of growth factors in the pathogenesis of diabetic retinopathy
Grant, M. B., Afzal, A., Spoerri, P., Pan, H., Shaw, L. C., & Mames, R. N. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.10.1275 · Cited by 171
Anti‐VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases
NG, E. W. M., & ADAMIS, A. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.062 · Cited by 161
Funatsu, H., Yamashita, H., Nakanishi, Y., & Hori, S. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.3.311 · Cited by 146
Funk, M., Schmidinger, G., Maár, N., Bolz, M., Benesch, T., Zlabinger, G. J., & Schmidt-Erfurth, U. M. (2010) · Retina · doi:10.1097/iae.0b013e3181e095c0 · Cited by 133
Self-citationPathophysiology of Diabetic Macular Edema
Singh, A. K., & Stewart, J. M. (2009) · International Ophthalmology Clinics · doi:10.1097/iio.0b013e31819fd164 · Cited by 53
Update on treatments for diabetic macular edema
Fraser‐Bell, S., Kaines, A., & Hykin, P. (2008) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e3282fb7c45 · Cited by 49
Anti-VEGF Therapeutic Approaches for Diabetic Macular Edema
Khurana, R. N., Diana, V., & Nguyen, Q. D. (2009) · International Ophthalmology Clinics · doi:10.1097/iio.0b013e31819fd8b5 · Cited by 14
Self-citation
Cited by
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
The Diabetic Retinopathy Clinical Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414264 · Cited by 1,607
Wong, T. Y., Cheung, C. M. G., Larsen, M., Sharma, S., & Simó, R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.12 · Cited by 1,094
Intravitreal Aflibercept for Diabetic Macular Edema
Korobelnik, J.-F., Do, D. V., Schmidt-Erfurth, U., Boyer, D. S., Holz, F. G., Heier, J. S., Midena, E., Kaiser, P. K., Terasaki, H., Marcus, D. M., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.05.006 · Cited by 816
Self-citationDiabetic Retinopathy Preferred Practice Pattern®
Flaxel, C. J., Adelman, R. A., Bailey, S. T., Fawzi, A., Lim, J. I., Vemulakonda, G. A., & Ying, G.-S. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.09.025 · Cited by 717
Schmidt-Erfurth, U., Garcia-Arumi, J., Bandello, F., Berg, K., Chakravarthy, U., Gerendas, B. S., Jonas, J., Larsen, M., Tadayoni, R., & Loewenstein, A. (2017) · Ophthalmologica · doi:10.1159/000458539 · Cited by 703
Self-citation
Metadata
- Authors
- Do, D. V., Nguyen, Q. D., Boyer, D., Schmidt-Erfurth, U., Brown, D. M., Vitti, R., Berliner, A. J., Gao, B., Zeitz, O., Ruckert, R., Schmelter, T., Sandbrink, R., & Heier, J. S.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 119
- Issue
- 8
- Pages
- 1658-1665
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2156799887
- Cited by
- 385
- References
- 33
- FWCI
- 39.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.